You are here

A Pharmacoeconomic Model for Making Value-Based Decisions About Serotonin Reuptake Inhibitors

Patrick W. Sullivan, PhD; Robert Valuck, PhD, RPh; Diana I. Brixner, PhD; Edward P. Armstrong, PharmD
PDF version: 
The authors discuss formulary considerations for the largest therapeutic class of prescription drugs and their efficacy in treating depression and anxiety.